Atlas Trials

A Study of PCSK9 Inhibitor AK102 in Healthy Subjects

Clinical trial NCT04169386 · COMPLETED

Trial details

NCT number
NCT04169386
Sponsor
Akeso
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hypercholesterolaemia
Start date
2018-05-23
Primary completion
2018-11-22
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.